Together, we can turn groundbreaking concepts into impactful solutions.

Partnering with government, institutions, foundations, and nonprofits, we tackle pressing health challenges efficiently through the power of collaboration. Our experienced team of experts in science, medicine, engineering, and business work alongside our partners to identify and nurture high-potential health innovation projects. 

The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Moving Ideas Forward

  • Proven Processes: Streamlined methodologies that ensure efficiency and effectiveness. 
  • Hands-On Facilitation: Direct, personalized assistance at every step of the innovation process.
  • Global Network: Access to a world-class network of experts ready to lend insights and experience.
  • Customized Tools: Tailored infrastructure, tools, and resources designed to fit the needs of your project.  

     

Where We Excel

  • Spotting highly promising projects.
  • Engaging the world’s leading experts.
  • Minimizing risk through our Deep Dive evaluation.
  • Maximizing speed and efficiency with the support of tailored tools.
  • Accelerating development through our proven process.

 

 

Our Impact

We have supported more than 1,200 innovator teams, evaluated more than 5,000 ideas, and helped develop more than a thousand health innovations. Our efforts have resulted in:

  • 49% commercialization success rate.
  • $2 billion in follow-on funding.
  • 1000+ healthcare innovations developed.
  • touching millions of lives.

 

Innovation Spotlight

Innovation Spotlight

Webinar - COVID Vaccines Immunity and Variants

Webinar - COVID Vaccines: Immunity and Variants

The COVID-19 pandemic has claimed an estimated 15 million lives, including more than 1 million lives in the United States alone. The rapid development of multiple COVID-19 vaccines has been a triumph of biomedical research, and billions of vaccine doses have been administered worldwide. Join this webinar to learn about the current state of knowledge about immune responses to COVID-19 vaccines and the importance of both humoral and cellular immunity for durable protection against severe disease.

When:
February 14th
2PM ET

Speaker: 
Dan Barouch, M.D., Ph.D.
William Bosworth Castle Professor of Medicine
Harvard Medical School
Ragon Institute of MGH, MIT, and Harvard
Director, Center for Virology and Vaccine Research
Beth Israel Deaconess Medical Center

Watch the recording >